MaryRinellaMD
Gastroenterology • Chicago, ILHepatology & Liver Transplantation
Associate Professor in Medicine-Gastroenterology and Hepatology, Northwestern University Medical School
Dr. Rinella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
680 N Lake Shore Dr
Ste 1000
Chicago, IL 60611Phone+1 312-695-9797Fax+1 312-695-0042
Education & Training
University of ChicagoResidency, Internal Medicine, 1996 - 1999
University of Illinois College of MedicineClass of 1996
Certifications & Licensure
IL State Medical License 1999 - 2026- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH Start of enrollment: 2005 Mar 01
- Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients. Start of enrollment: 2006 Sep 01
- Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial.Philip N Newsome, Arun J Sanyal, Kristiane A Engebretsen, Iris Kliers, Laura Østergaard
Alimentary Pharmacology & Therapeutics. 2024-12-01 - 7 citationsExpert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced...Mazen Noureddin, Michael R Charlton, Stephen A Harrison, Meena B Bansal, Naim Alkhouri
Clinical Gastroenterology and Hepatology. 2024-12-01 - Body composition and muscle composition phenotypes in patients on waitlist and shortly after liver transplant - results from a pilot study.Mikael F Forsgren, Stewart Pine, Claire Royalle Harrington, Dyanna Gregory, Mikael Petersson
BMC Gastroenterology. 2024-10-09
Journal Articles
- Mechanisms of NAFLD Development and Therapeutic StrategiesArun J Sanyal, Mary Rinella, Scott L Friedman, Nature
Press Mentions
This Disease Can Damage the Liver for Years Without Being DetectedOctober 8th, 2024- 4 Ways to Reverse Nonalcoholic Fatty Liver DiseaseMay 24th, 2023
- People With Obesity or Type 2 Diabetes Should Be Screened for Fatty Liver DiseaseJanuary 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
- Member
- AASLDMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
